PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced updated data from the Phase 2 pivotal portion of the ongoing PYNNACLE clinical trial. Results were presented today in an oral presentation by Alison M. Schram, M.D., Medical Oncologist at Memorial Sloan Kettering Cancer Center and PYNNACLE Study Investigator, at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics taking place in Boston, Massachusetts. The ongoing Phase 1/2 PYNNACLE clinical trial is …

The move could help the payment product's big bank owners head off cryptocurrency competition.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) breached their fiduciary duties to shareholders. If you currently own BioXcel stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about.

Alpine Income Property Trust, Inc. (NYSE:PINE ) Q3 2025 Earnings Call October 24, 2025 9:00 AM EDT Company Participants Jenna McKinney John Albright - President, CEO & Director Philip Mays - Senior VP, CFO & Treasurer Conference Call Participants Michael Goldsmith - UBS Investment Bank, Research Division R.J. Milligan - Raymond James & Associates, Inc., Research Division Alec Feygin - Robert W.

Kinsale Capital Group, Inc. (NYSE:KNSL ) Q3 2025 Earnings Call October 24, 2025 9:00 AM EDT Company Participants Michael Kehoe - Chairman of the Board & CEO Bryan Petrucelli - Executive VP, CFO & Treasurer Brian Haney - President, COO & Director Stuart Winston - Executive VP & Chief Underwriting Officer Conference Call Participants Jian Huang - Morgan Stanley, Research Division Michael Phillips - Oppenheimer & Co. Inc., Research Division Michael Zaremski - BMO Capital Markets Equity Research Mark Hughes - Truist Securities, Inc., Research Division Andrew Andersen - Jefferies LLC, Research Division Andrew Kligerman - TD Cowen, Research Division …

Halloween is a few days away, but regional banks may have already hit their quota of scares for the month. From poor loan performance to fraud charges to subprime bankruptcies, regional banks were giving investors plenty of reasons to stay away.

Marvell Technology gains an edge over Synopsys in the fast-growing AI and data center interconnect market as Synopsys faces margin and competition pressures.

XYL readies its Q3 report, with strong infrastructure and smart metering demand expected to drive steady top-line growth.

Biogen is expected to top earnings forecasts again as new products offset declining multiple sclerosis drug sales.

Enterprise Products readies its Q3 2025 report as stable pipeline revenues and higher gas margins meet expectations for softer overall sales.

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

CCL and LVS shine with robust Q3 earnings, upbeat travel demand, and optimistic growth forecasts for 2025 and beyond.

GRMN's Q3 earnings are on deck, with rising demand for wearables and marine tech expected to drive strong revenue growth.

PSX gears up for Q3 results as softer crude prices and steady midstream income shape expectations for its refining-driven performance.

FMX's digital push, U.S. distribution expansion and OXXO Gas growth fuel momentum despite ongoing margin pressures.

Deckers tops Q2 forecasts as HOKA and UGG drive double-digit sales growth, boosting margins and supporting its fiscal 2026 outlook.

Making outlandish claims makes news. I remember in 1999, when the Dow was trading right around 11,000 that the “infamous” book Dow 36000 by James Glassman and Kevin Hassett came out.

Applied Materials (AMAT) surged by 52% over the last six months, propelled not only by strong revenue and margin improvements but also by a remarkable increase in market confidence.

Universal Insurance Holdings, Inc. (NYSE:UVE ) Q3 2025 Earnings Call October 24, 2025 10:00 AM EDT Company Participants Arash Soleimani - Chief Strategy Officer Stephen Donaghy - CEO & Director Frank Wilcox - Chief Financial Officer Conference Call Participants Jon Paul Newsome - Piper Sandler & Co., Research Division Nicolas Iacoviello - Dowling & Partners Securities, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to Universal's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

Eagle Financial Services, Inc. (NASDAQ:EFSI ) Q3 2025 Earnings Call October 24, 2025 10:00 AM EDT Company Participants Nicholas Smith Brandon Lorey - President, CEO & Director Kathleen Chappell - Executive VP & CFO Joseph Zmitrovich - President & Chief Banking Officer of Bank of Clarke Presentation Operator Thank you for standing by. My name is Carly, and I will be your conference operator today.